Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Child & Adolescent Health; October 2020, Vol. 4 Issue: 10 p728-739, 12p
- Subject
- Language
- ISSN
- 23524642; 23524650